The long-term objective of this revision application is to test hypotheses that overall anticholinergic (AC) medication exposure is associated with poor cognitive and physical performance outcomes in older adults using a novel and comprehensive assessment of AC exposure. The current paradigm is that AC medication use has reversible adverse effects on cognition, but this assumption has been challenged suggesting more detrimental permanent effects.
The Specific Aims are:
Aim 1 : Determine whether cumulative and long-term AC burden is associated with: (1.a.) increased incidence of all-cause dementia or Alzheimer's disease (AD);and (1.b.) higher burden of neuropathological markers of dementia or AD (neuritic plaques, neurofibrillary tangles, amyloid angiopathy);
Aim 2 : Determine whether current anticholinergic burden is associated with greater decline in physical performance (gait speed, composite score of lower extremity function);
Aim 3 : Establish a system and infrastructure for data resource sharing through transfer of biospecimens and data using the established procedure of the National Cell Repository for Alzheimer's Disease (NCRAD) and continue our active collaboration with the Alzheimer's Disease Genetics Consortium (ADGC). This application will utilize the Adult Changes in Thought (ACT) study which is a 17 year longitudinal study of risk factors for incident dementia. ACT has enrolled over 4000 subjects from Group Health, a large integrated health maintenance organization. The ACT study is a unique data resource;it provides a community-based cohort with longitudinal objective assessments (every 2 years) of physical and cognitive function, autopsy data for examination of neuropathological correlates of dementia, and high quality exposure information from automated pharmacy records extending back 15 years prior to ACT study baseline. The availability of detailed automated pharmacy data will allow us to significantly improve the quantification of AC use over prior studies by our ability to examine cumulative long-term AC exposure and to quantify dose and duration of each AC medication.

Public Health Relevance

Up to 25% of older adults are using AC drugs. Clinical practice would be significantly impacted if we find that long-term AC use is associated with a higher risk for dementia. It would provide a compelling reason to minimize long-term AC use and could pave the way to develop focused interventions to reduce AC drug use. This proposal will also enhance genetic and other data sharing from one of the most important ongoing studies of aging in the world

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Anderson, Dallas
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Group Health Cooperative
United States
Zip Code
Beecham, Gary W; Hamilton, Kara; Naj, Adam C et al. (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet 10:e1004606
Escott-Price, Valentina; Bellenguez, CĂ©line; Wang, Li-San et al. (2014) Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. PLoS One 9:e94661
Nelson, Peter T; Estus, Steven; Abner, Erin L et al. (2014) ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol 127:825-43
Postupna, Nadia O; Keene, C Dirk; Latimer, Caitlin et al. (2014) Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease. Lab Invest 94:1161-72
Gross, Alden L; Sherva, Richard; Mukherjee, Shubhabrata et al. (2014) Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets. Neuroepidemiology 43:194-205
Ennis, Stephanie K; Larson, Eric B; Grothaus, Louis et al. (2014) Association of living alone and hospitalization among community-dwelling elders with and without dementia. J Gen Intern Med 29:1451-9
Dublin, Sascha; Anderson, Melissa L; Heckbert, Susan R et al. (2014) Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J Gerontol A Biol Sci Med Sci 69:609-15
Benitez, Bruno A; Jin, Sheng Chih; Guerreiro, Rita et al. (2014) Missense variant in TREML2 protects against Alzheimer's disease. Neurobiol Aging 35:1510.e19-26
Brenowitz, Willa D; Hubbard, Rebecca A; Crane, Paul K et al. (2014) Longitudinal associations between self-rated health and performance-based physical function in a population-based cohort of older adults. PLoS One 9:e111761
Kim, Jong Hun; Song, Pamela; Lim, Hyunsun et al. (2014) Gene-based rare allele analysis identified a risk gene of Alzheimer's disease. PLoS One 9:e107983

Showing the most recent 10 out of 169 publications